Insys Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Insys Therapeutics generated cash of -$55,989,000, which is more than the previous year. Cash used in financing activities reached the amount of $2,144,000 last year. Net change in cash is therefore -$447,000.
Cash Flow
| 2013 | 24.24M | -5.52M | 26.29M |
|---|---|---|---|
| 2014 | 49.66M | -69.88M | 32.94M |
| 2015 | 100.85M | -88.74M | 9.30M |
| 2016 | 58.90M | -22.03M | -11.74M |
| 2017 | -60.66M | -17.81M | 5.82M |
| 2018 | -55.98M | 53.39M | 2.14M |
INSY Cash Flow Statement (2013 – 2018)
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 31.99M | 104.64M | 79.51M | 58.10M | 45.38M | 361K |
Operating activities | ||||||
Net income | -124.50M | -228.01M | 7.59M | 58.47M | 37.97M | 40.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 7.60M | 8.46M | 8.27M | 5.29M | 2.5M | 1.78M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 6.33M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 6.33M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 8.90M | -859K | 26.61M | -21.91M | -10.23M | -13.22M |
Inventories | 2.26M | 2.25M | 15.04M | -6.93M | -20.25M | -7.43M |
Accounts payable | 15.80M | -11.60M | -18.48M | 52.21M | 50.37M | 14.41M |
Cash generated by operating activities | -55.98M | -60.66M | 58.90M | 100.85M | 49.66M | 24.24M |
Investing activities | ||||||
Purchases Of Investments | -61.72M | -132.06M | -16.09M | -91.36M | -48.04M | 0 |
Investments In Property Plant And Equipment | -6.09M | -16.66M | -10.61M | -13.84M | -22.24M | -5.12M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 53.39M | -17.81M | -22.03M | -88.74M | -69.88M | -5.52M |
Financing activities | ||||||
Common Stock Issued | 1.04M | 1.32M | 2.28M | 2.64M | 1.98M | 32.45M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -1.98M |
Repurchases of common stock | -31.55M | -31.99M | -16.09M | -16.45M | -58.10M | -45.38M |
Repayments of term debt | -13.39M | 0 | -10.74M | 0 | -2.97M | -991K |
Cash used in financing activities | 2.14M | 5.82M | -11.74M | 9.30M | 32.94M | 26.29M |
Net Change In Cash | -447K | -72.64M | 25.12M | 21.40M | 12.72M | 45.02M |
Cash at end of period | 31.55M | 31.99M | 104.64M | 79.51M | 58.10M | 45.38M |
| Data source | Data source | Data source | Data source | Data source | Data source |